Patents by Inventor Curt D. Wolfgang

Curt D. Wolfgang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of treatment based on polymorphisms of the KCNQ1 gene
    Patent number: 9157121
    Abstract: The invention provides methods for the administration of compounds capable of prolonging a QTc interval and methods for predicting whether an individual is predisposed to such QTc prolongation.
    Type: Grant
    Filed: February 26, 2015
    Date of Patent: October 13, 2015
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
    Publication number: 20150258083
    Abstract: The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
    Type: Application
    Filed: May 13, 2015
    Publication date: September 17, 2015
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE
    Publication number: 20150167091
    Abstract: The invention provides methods for the administration of compounds capable of prolonging a QTc interval and methods for predicting whether an individual is predisposed to such QTc prolongation.
    Type: Application
    Filed: February 26, 2015
    Publication date: June 18, 2015
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • Method of treatment based on polymorphisms of the KCNQ1 gene
    Patent number: 8999638
    Abstract: The invention provides methods for the administration of compounds capable of prolonging a QTc interval and methods for predicting whether an individual is predisposed to such QTc prolongation.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: April 7, 2015
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20150045390
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: March 14, 2013
    Publication date: February 12, 2015
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • METHOD AND COMPOSITION FOR TREATING AN ALPHA ADRENOCEPTOR-MEDIATED CONDITION
    Publication number: 20140194459
    Abstract: Methods and compositions for the treatment of alpha-adrenoceptor mediated conditions.
    Type: Application
    Filed: March 5, 2014
    Publication date: July 10, 2014
    Applicant: Vanda Pharmaceuticals, Inc.
    Inventors: Mihael H. Polymeropoulos, Paolo Baroldi, Curt D. Wolfgang
  • Method and composition for treating an alpha adrenoceptor-mediated condition
    Patent number: 8729100
    Abstract: Methods and compositions for the treatment of alpha-adrenoceptor mediated conditions.
    Type: Grant
    Filed: December 13, 2008
    Date of Patent: May 20, 2014
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Mihael H. Polymeropoulos, Paolo Baroldi, Curt D. Wolfgang
  • Methods for the administration of iloperidone
    Patent number: 8586610
    Abstract: The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: November 19, 2013
    Assignee: Vanda Pharmaceuticals, Inc.
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • METHOD OF TREATMENT BASED ON POLYMORPHISMS OF THE KCNQ1 GENE
    Publication number: 20120027871
    Abstract: The invention provides methods for the administration of compounds capable of prolonging a QTc interval and methods for predicting whether an individual is predisposed to such QTc prolongation.
    Type: Application
    Filed: April 5, 2010
    Publication date: February 2, 2012
    Applicant: VANDA PHARMACEUTICALS, INC.
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • METHOD AND COMPOSITION FOR TREATING AN ALPHA ADRENOCEPTOR-MEDIATED CONDITION
    Publication number: 20100273809
    Abstract: Methods and compositions for the treatment of alpha-adrenoceptor mediated conditions.
    Type: Application
    Filed: December 13, 2008
    Publication date: October 28, 2010
    Inventors: Mihael H. Polymeropoulos, Paolo Baroldi, Curt D. Wolfgang
  • TREATMENT FOR DEPRESSIVE DISORDERS
    Publication number: 20090306137
    Abstract: A method of treating depression comprising administering a melatonin agonist.
    Type: Application
    Filed: May 21, 2007
    Publication date: December 10, 2009
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos
  • METHODS FOR THE ADMINISTRATION OF ILOPERIDONE
    Publication number: 20090298880
    Abstract: The present invention relates to methods for the identification of genetic polymorphisms that may be associated with a risk for QT prolongation after treatment with iloperidone and related methods of administering iloperidone to patients with such polymorphisms.
    Type: Application
    Filed: September 30, 2005
    Publication date: December 3, 2009
    Inventors: Curt D. Wolfgang, Mihael H. Polymeropoulos